Launched in 2021, Sequence prescribes weight-loss drugs like Ozempic and Wegovy online while helping patients navigate reimbursement and insurance.
Goldman Sachs estimates that sales for obesity drugs like GLP-1s could reach $30 billion annually by 2032. Analysts said in a Monday note that the potential market for such treatments is around 15 million people in the US today, a number that could grow to 31 million in 2030.
While the media glorifies obesity. Lol nice try
Finance Finance Latest News, Finance Finance Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MarketWatch - 🏆 3. / 97 Read more »
Source: MarketWatch - 🏆 3. / 97 Read more »